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Abstract Glucagon is the major hormone activating glycogen-
olysis and gluconeogenesis both localized in the periportal, more
aerobic zone of the liver. Accordingly, the glucagon receptor
(GcgR) mRNA was found to be predominantly expressed in this
area. In hepatocyte cultures high glucose concentrations as
reached after a meal induced GcgR mRNA under arterial but not
venous pO2. The induction by glucose was partially antagonized
by insulin and unaffected by glucagon. The modulation by O2 of
the glucose-dependent induction would contribute to the zonated
expression of GcgR mRNA.
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1. Introduction
Glucagon, a 29 amino acid peptide, activates hepatic glu-
cose production by glycogenolysis and gluconeogenesis. The
rat [1], mouse [2] and human [3] glucagon receptor genes have
been cloned. They encode a protein of 485 amino acids with a
predicted molecular size of 55 kDa [1]. The glucagon receptor
is closely related to the receptors for glucagon-like peptide-1,
gastric inhibitory polypeptide, secretin and vasoactive intesti-
nal polypeptide [1,4]. It belongs to the superfamily of G-pro-
tein-coupled receptors having seven putative transmembrane
domains and activates adenylate cyclase [1].
The major target organ for glucagon is the liver which ex-
hibits a heterogeneous distribution of key enzymes and sub-
cellular structures between periportal and perivenous areas.
The zonal enzyme distribution in conjunction with functional
studies led to the model of metabolic zonation [5^8]. Accord-
ingly, glucose release from glycogenolysis and gluconeogenesis
takes place preferentially in the periportal area; conversely,
glucose uptake for glycogen synthesis and glycolysis occurs
mainly in the perivenous area. Due to metabolism and elim-
ination, concentration gradients of substrates such as oxygen
and hormones are formed during a single passage of blood
through the liver [6,8] : For oxygen, glucagon and insulin a
2-fold periportals perivenous gradient is established; for in-
sulin the gradient is reduced to 1.2-fold during meals. Thus,
during the absorptive phase the ratio of insulin versus its
antagonist glucagon increases from the periportal to the peri-
venous zone. The gradients in oxygen, glucagon and insulin
were considered to be key regulators for the zonal expression
of the genes of carbohydrate-metabolizing enzymes [6^8].
Since the glucagon-stimulated processes of glycogenolysis
and gluconeogenesis occur predominantly in the periportal
zone, the glucagon receptor gene would be expected to be
expressed mainly in this more aerobic area. Therefore, it
was the aim of this study to investigate the possible zonation
of GcgR mRNA in rat liver and to study the regulation of its
expression by the substrates glucose and O2 as well as the
hormones glucagon and insulin in primary rat hepatocyte
cultures. In line with expectations GcgR mRNA was predom-
inantly localized periportally and could be induced in primary
hepatocyte cultures by glucose only under periportal but not
perivenous pO2. Insulin partially antagonized the induction
by glucose, but glucagon had no e¡ect. The induction of
GcgR mRNA by glucose in the absorptive phase would pre-
pare the cell for the following postabsorptive phase. The glu-
cose-antagonistic action of insulin might function to prevent
an overinduction by glucose.
2. Materials and methods
2.1. Chemicals
All chemicals were of reagent grade and purchased from commer-
cial suppliers. Collagenase, digoxigenin-UTP, the digoxigenin nucleic
acid detection kit, T3 and T7 RNA polymerase, CSPD (disodium
3-(4-methoxyspiro(1,2-dioxetane-3,2P-(5Pchloro) tricyclo[3.3.1.13:7] de-
can)-4-yl)phenyl phosphate), DIG RNA labelling mixture and fetal
calf serum were from Boehringer (Mannheim), medium M199 from
Gibco BRL (Eggenstein). Hormones were delivered from Serva (Hei-
delberg). Guanidinium thiocyanate was purchased from Fluka (Neu-
Ulm). All other chemicals were from Sigma (Taufkirchen). The
BLUESCRIPT vector (pBS) was from Stratagene (Heidelberg).
2.2. Cell culture experiments
Liver cells were isolated by collagenase perfusion. Cells (1U106 per
dish) were maintained under standard conditions in an atmosphere of
16% O2, 79% N2, and 5% CO2 (by vol.) in medium M199 containing
0.5 nM insulin added as a growth factor for culture maintenance,
100 nM dexamethasone required as a permissive hormone and 4%
fetal calf serum for the initial 4 h of culture. After 4 h cells were
cultured in serum-free M199 under 16% O2 (mimicking arterial O2
tensions) or 8% O2 (mimicking venous O2 tensions) with additions as
described in the legends to ¢gures. The O2 values take into account
the O2 di¡usion gradient from the media surface to the cells [9].
2.3. RNA preparation and Northern analysis
Total RNA was prepared from 3U106 cells as described [10]. Forty
Wg RNA were denatured by formaldehyde and used in a typical
Northern experiment. Digoxigenin (DIG)-labelled antisense GcgR,
PCK1 and L-actin RNA served as hybridization probes. Respective
cDNAs of GcgR (1092 bp; nucleotide 247^1338; GenBank: L04796)
and L-Act (588 bp; nucleotide 69^618; EMBL: HSAC07) were cloned
into pBS and transcribed into antisense RNA by using T7 RNA
polymerase and DIG RNA labelling mixture. PCK1 antisense RNA
was synthesized from pBS-PCK containing a 1200 bp PstI cDNA
fragment [11] by using T3 RNA polymerase and DIG RNA labelling
FEBS 19701 9-1-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 1 5 5 6 - 1
*Corresponding author. Fax: +49 551 395960.
E-mail: kjunger@gwdg.de
Abbreviations: L-Act, L-actin; DIG, digoxigenin; Gcg, glucagon;
GcgR, glucagon receptor; Glc, glucose; Ins, insulin; PCK1, cytosolic
phosphoenolpyruvate carboxykinase
FEBS 19701FEBS Letters 421 (1998) 136^140
mixture. Hybridizations were carried out with 50 ng/ml transcript at
65‡C according to the DIG nucleic acid detection kit (Boehringer
Mannheim). Detection of hybrids was performed by enzyme-linked
immunoassay using an anti-digoxigenin alkaline phosphatase conju-
gate. Hybrids were visualized via chemiluminescence with CSPD. Lu-
minescent blots were exposed to Hyper¢lm-MP (Amersham,
Braunschweig) and quanti¢ed with a videodensitometer (Biotech
Fischer, Reiskirchen).
2.4. In situ hybridization
Liver tissue of normal fed rats was embedded in para⁄n. Then 5 Wm
sections were prepared. Para⁄n was removed from the liver sections
by xylene. The sections were then rehydrated with descending ethanol
concentrations and ¢nally equilibrated in PBS. They were then per-
meabilized in 0.3% Triton X-100, 10 Wg/ml proteinase K and 4 mg/ml
glucosidase for 15 min at 37‡C and ¢nally incubated in 0.1 M trie-
thanolamine pH 8.0 containing 0.25% acetic acid anhydride for
10 min. For hybridization digoxigenin-labelled RNA transcripts
were hydrolysed to a length of 200^300 bp in the presence of Na2CO3
bu¡er, pH 10.2. Hybridization was performed overnight with 25 ng
RNA probes at 42‡C (PCK1) or 45‡C (GcgR) in 100 Wl hybridization
solution containing 50% formamide, 10% dextrane sulfate, 1U Den-
hardts (0.02% bovine serum albumin, 0.02% Polyvinilpyrrolidon,
0.02% Ficoll) and 0.5 mg/ml each E. coli DNA in 4U SSC (sodium
chloride-sodium citrate: 0.6 M NaCl, 0.06 M sodium citrate, pH 7.0).
After hybridization, sections were washed in 4U SSC and unhybri-
dized RNA was digested by incubation with RNase A (10 Wg/ml) for
30 min. Bound digoxigenin-labelled hybrids were detected by enzyme-
linked immunoassay using an anti-digoxigenin alkaline phosphatase
conjugate and visualized via color reaction with nitroblue tetrazolium
and 5-bromo-4-chloro-3-indolyl phosphate as substrates (Boehringer
Mannheim).
3. Results
The possible zonated expression of GcgR mRNA in the
liver of normal fed rats was studied by in situ hybridization.
Primary rat hepatocyte cultures were used to study the in£u-
ence of the substrates glucose, oxygen and the hormones in-
sulin and glucagon as possible determinants for the zonated
gene expression.
3.1. Periportal localization of glucagon receptor mRNA
in rat liver
The GcgR mRNA abundance in livers of fed and 24 h
fasted rats as revealed by Northern analysis was not signi¢-
cantly di¡erent (not shown). In situ hybridization with paraf-
¢n-embedded sections from livers of normal fed rats showed
that GcgR mRNA was localized predominantly in the peri-
portal zone of the liver acinus (Fig. 1). In parallel sections
PCK1 mRNA, which served as a periportal marker [11], could
be localized also in the same periportal area as GcgR mRNA
(Fig. 1) and glutamine synthetase mRNA, which is a perive-
nous marker [12,13], was found to be expressed in the distal
perivenous area only (not shown).
Thus, GcgR mRNA was predominantly expressed in the
periportal area, in which the glucagon-activated pathways of
glycogenolysis and gluconeogenesis had been localized previ-
ously [6,8,14].
3.2. Induction of glucagon receptor mRNA by glucose under
periportal but not perivenous pO2 in primary hepatocyte
cultures
In 4 h rat hepatocyte cultures the expression of GcgR
mRNA was induced within 24 h by increasing glucose con-
centrations from 5 mM up to 50 mM only under periportal
pO2. There was no induction by glucose of GcgR mRNA
under perivenous pO2 (Fig. 2). Twenty-¢ve mM glucose in-
duced GcgR mRNA by about 2.3-fold and 50 mM by about
3.5-fold. The increase of GcgR mRNA by 25 mM glucose was
essentially linear with time within 24 h (Fig. 3). A glucose
concentration of 25 mM was then chosen for further experi-
ments. The same results were obtained (not shown), when
cells were cultured for 24 h and then induced for the following
24 h with the same glucose concentrations and under the same
oxygen partial pressures. As a control the induction by glu-
cose of pyruvate kinase L was studied [15]. 25 mM glucose
increased pyruvate kinase L mRNA by 2-fold within 24 h (not
shown).
Thus, increasing glucose concentrations as reached in the
portal vein after a meal enhanced GcgR mRNA in hepatocyte
cultures only under periportal pO2 in accord with the peripor-
tal expression of GcgR mRNA in rat liver (Fig. 1).
3.3. Modulation by insulin and glucagon under periportal pO2
of the glucose-dependent induction of GcgR mRNA in
primary hepatocyte cultures
In another series of experiments with primary rat hepato-
cyte cultures the in£uence of insulin and glucagon on GcgR
mRNA expression was investigated. Twenty-¢ve mM glucose
induced GcgR mRNA maximally to about 350% within 24 h.
Addition of 100 nM insulin reduced the glucose-dependent
induction of GcgR mRNA to about 200%, while the presence
of 10 nM glucagon was without e¡ect. However, 10 nM glu-
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Fig. 1. Periportal zonation of glucagon receptor mRNA in rat liver.
Five Wm parallel sections were prepared from livers of rats kept
under a normal daily feeding cycle. mRNAs were localized by in
situ hybridization using a DIG-labelled GcgR and PCK1 antisense
RNA probe (cf. Section 2); dark precipitates indicate high levels of
GcgR mRNA and PCK mRNA, respectively, in the periportal area.
pp, periportal; pv, perivenous.
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cagon given in combination with 100 nM insulin abolished the
impairment by insulin of the glucose-dependent induction of
GcgR mRNA (Fig. 4).
Thus, insulin partially inhibited the glucose-dependent in-
duction of GcgR mRNA and glucagon as the major insulin
antagonist counteracted the insulin action.
4. Discussion
The mRNA of the GcgR was predominantly expressed in
the periportal more oxygenated zone of the rat liver acinus
(Fig. 1). In rat hepatocyte cultures high absorptive glucose
concentrations increased the GcgR mRNA levels only under
high periportal pO2 but not under perivenous pO2. This pO2-
dependent induction might explain the periportal expression
of the GcgR gene.
4.1. Zonation of glucagon receptor gene expression
According to the model of ‘metabolic zonation’ the gluca-
gon-stimulated glycogenolysis and gluconeogenesis occur
mainly in the more aerobic periportal zone of the liver acinus
[6^8]. Thus, the mainly periportal expression of GcgR mRNA
was in line with expectations. However, in a previous exami-
nation using antibodies against partially puri¢ed rat liver
GcgR, which recognized surface structures on liver, kidney
and adipocyte but not lung or erythrocyte membranes and
which did not inhibit the action of glucagon, the receptor
protein was localized mainly in the perivenous zone [16] ;
yet, in another study the same authors reported the periportal
localization of the GcgR protein [17]. If the antibodies were
speci¢c, it is di⁄cult to explain the apparently con£icting
results.
4.2. Modulation of the zonated glucagon receptor gene
expression by the substrates O2 and glucose
4.2.1. Modulation by O2 of zonated gene expression. The
periportal to perivenous pO2 gradient was proposed to be a
key regulator for the zonation of gene expression [6^8]. In
primary rat hepatocyte cultures glucose induced the GcgR
mRNA to maximal levels under periportal pO2 but not under
perivenous pO2 (Figs. 2 and 3). Thus, during the postabsorp-
tive phase at normal 5 mM glucose GcgR mRNA would be
expressed homogeneously to basal levels in periportal and
perivenous cells, but during the absorptive phase at postpran-
dial s 10 mM glucose in the portal vein GcgR mRNA ex-
pression would be enhanced in the periportal O2-rich zone
only, so that on average a periportals perivenous zonation
of GcgR mRNA results (Fig. 1). The modulatory role of O2 is
in line with the previous observations that glucagon activated
the gluconeogenic key enzyme gene PCK1 maximally under
periportal pO2 [10,18] and, reciprocally, that insulin activated
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Fig. 3. Time course of the induction by glucose of glucagon recep-
tor mRNA under periportal pO2 in primary rat hepatocyte cultures.
A: Cells were cultured as described in Fig. 2 with the glucose con-
centration raised from 5 to 25 mM. mRNA was analyzed by North-
ern blotting as in Fig. 2. In each experiment the basal mRNA level
with 5 mM Glc under arterial pO2 at each time point was set to
100%. Values are means þ S.E.M. of three independent culture ex-
periments. Statistics : Student’s t-test for paired values: *P9 0.05.
B: Representative Northern blot; 40 Wg total RNA was analyzed.
Fig. 2. Induction of glucagon receptor mRNA by glucose under
periportal but not perivenous pO2 in primary rat hepatocyte cul-
tures. Cells were cultured for 4 h under arterial pO2 (16% O2) and
basal glucose (5 mM). The basal 5 mM glucose concentration is
that of the culture medium M199. Then glucose was added to the
¢nal indicated concentrations and the cells were further cultured
under arterial and venous pO2 (8% O2) for another 24 h. In each
experiment the mRNA level with basal glucose under arterial pO2
measured by Northern blotting was set to 100%. Northern blots
with 40 Wg of total RNA from cultured rat hepatocytes were hybri-
dized to a DIG-labelled GcgR and L-actin antisense RNA probe
(cf. Section 2). Chemiluminescent signals were quanti¢ed by video-
densitometry. Values are means þ S.E.M. of three independent cul-
ture experiments. Statistics: Student’s t-test for paired values:
*P9 0.05.
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the glycolytic key enzyme gene glucokinase maximally under
perivenous pO2 [19].
The modulation by O2 of the induction of the PCK1 and
glucokinase genes appears to be mediated by H2O2 as the
intracellular mediator [18,19], which could be formed by a
CO-sensitive heme-containing oxidase as the oxygen sensor
[20,21].
Thus, the positive modulation by O2 of the glucose-depend-
ent GcgR mRNA induction and the glucagon-dependent
PCK1 gene activation would explain the predominant peri-
portal localization of GcgR mRNA and PCK mRNA in rat
liver.
4.2.2. Modulation by glucose of zonated gene expression.
Glucose plays an important role in the regulation of gene
expression in mammals [22^24]. It is known to induce the
expression of the glycolytic enzyme gene pyruvate kinase L
in hepatocytes and the lipogenic enzyme genes acetyl-CoA
carboxylase and fatty acid synthase in liver and adipose tissue.
In primary hepatocyte cultures glucose induced the GcgR
mRNA (Figs. 2 and 3). Since glucagon and consequently
the GcgR are functionally linked to glucose release rather
than uptake, one would have expected a repressive rather
than an inductive e¡ect of the ‘product’ glucose. However, a
similar paradoxical e¡ect of glucose was found previously: (1)
An about 2-fold induction of GcgR mRNA in the presence of
22.5 mM glucose was reported in cultured rat pancreatic islets
within 48 h [25] and rat hepatocytes within 24 h [26]. (2) Also,
an about 2-fold increase in luciferase activity by 25 mM glu-
cose was observed in the insulinoma cell line INS-1 within 45 h
after transfection with a construct driven by the gene pro-
moter of the glucose releasing, periportally localized glucose-
6-phosphatase [27]. In none of these studies were the time
dependences nor the O2 tensions, under which the cells were
cultured, reported so that a comparison of the e¡ectiveness of
the gene activation by glucose between the previous studies
and this work is not possible.
Glucose-dependent gene induction does not appear to be
mediated by a glucose sensor; it is believed to be mediated
through intermediates of glycolysis, glycogen synthesis or the
pentose phosphate pathway. It was suggested that glucose
induced gene expression through glucose-6-phosphate [24] or
metabolites of the nonoxidative branch of the pentose phos-
phate pathway, perhaps xylulose-5-phosphate [15,23].
A proposal for the physiological importance of the glucose-
dependent induction of the ‘glucogenic’ GcgR and glucose-6-
phosphatase genes has not been made [25^27]. Maybe, the
induction by glucose of GcgR mRNA in the absorptive phase
would prepare the cells for the following postabsorptive
phase.
4.3. Modulation of the zonated glucagon receptor gene
expression by the hormones insulin and glucagon
In liver and adipose tissue insulin increases the glucose-de-
pendent expression of glycolytic and lipogenic enzyme genes
indirectly by stimulating glucose uptake via an increase in
glucokinase or in plasma membrane glucose transporter-4 lev-
els, respectively [23,24,28,29], while glucagon enhances the
expression of gluconeogenic enzyme genes directly [29]. In
primary rat hepatocyte cultures insulin inhibited the glucose-
dependent induction of GcgR mRNA, glucagon alone had no
e¡ect but was antagonistic to insulin (Fig. 4). Since insulin is
functionally linked to glucose uptake and glucagon as well as
the GcgR to glucose release, one might have expected a re-
pressive action of insulin on GcgR expression. However, the
observed antagonism between insulin and glucose is surpris-
ing; yet, as outlined above, the underlying paradox is the
inductive action of glucose.
In the previous study with cultured rat hepatocytes [26] the
e¡ects of insulin, glucagon or both together on the induction
of GcgR mRNA by high glucose levels have not been inves-
tigated. Only the action of glucagon alone via cAMP, and
only at basal glucose concentrations, was studied and found
to be inhibitory. Thus, a comparison with the present work is
again not possible.
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Fig. 4. Induction of glucagon receptor mRNA by glucose under
periportal pO2 in primary rat hepatocyte cultures. Modulation of
insulin and glucagon. A: Cells were cultured as described in Fig. 2
with elevation of the glucose concentration from 5 to 25 mM and
the addition of 100 nM insulin or 10 nM glucagon, when indicated.
An additional 10 nM glucagon was added at 20 h. mRNA was
quanti¢ed by Northern blotting as in Fig. 2. In each experiment the
mRNA level with basal 5 mM Glc under arterial pO2 was set to
100%. Values are means þ S.E.M. of three independent culture ex-
periments. Statistics: Student’s t-test for paired values: *P9 0.05.
B: Representative Northern blot; 40 Wg total RNA was analyzed.
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Since in the absorptive phase insulin is degraded to a much
lesser extent than glucagon during a single passage of blood
through the liver, the insulin/glucagon ratio is higher in the
perivenous area [6^8]. Thus, the repression of the glucose-de-
pendent induction by higher insulin/glucagon ratios could
contribute to the lower levels of GcgR mRNA expression in
the perivenous zone. Moreover, it might function to prevent
an overinduction by glucose.
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